Leaderboards/Chronic Obstructive Pulmonary Disease (COPD) Research

Chronic Obstructive Pulmonary Disease (COPD) Research

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Gillian Doe
NIHR Leicester Biomedical Research Centre
2
Priya Venkatesan
Unknown
3
Xiaoye Fan
University of Science and Technology of China
4
Lifeng Lin
Guangdong Provincial Center for Disease Control and Prevention
5
Heini M. Natri
Translational Genomics Research Institute
6
Maude A. Liegeois
University of California, San Francisco
7
Shafaq Naeem
Wuhan University
8
Kiki Waeijen-Smit
Maastricht University Medical Centre
9
Mrinmayee Koltharkar
Unknown
10
Ricardo Polman
Maastricht University Medical Centre

Papers

1
Publication in The Lancet Respiratory Medicine (2024) [108 citations, W4405043050]
The Lancet Respiratory Medicine|2024
108 cit.
2
Cell-type-specific and disease-associated expression quantitative trait loci in the human lung
Nature Genetics|2024
92 cit.
3
Publication in Expert Review of Cardiovascular Therapy (2024) [76 citations, W4393182508]
Expert Review of Cardiovascular Therapy|2024
76 cit.
4
Publication in ERJ Open Research (2024) [46 citations, W4391839562]
ERJ Open Research|2024
46 cit.
5
Publication in BMC Medicine (2025) [34 citations, W4409212591]
BMC Medicine|2025
34 cit.
6
Publication in BMJ Open (2024) [12 citations, W4400202103]
BMJ Open|2024
12 cit.
7
Bi/Bi2S3-BiVO4 Z-scheme heterojunction one-dimensional composites with efficient photocatalytic degradation of tetracycline: Performance and mechanism insights
Colloids and Surfaces A Physicochemical and Engineering Aspects|2024
12 cit.
8
Development of a novel beads-like In/Fe co-doped BiVO4 composite for enhanced photocatalytic degradation of tetracycline in water
Colloids and Surfaces A Physicochemical and Engineering Aspects|2024
10 cit.
9
Publication in JAMA Network Open (2024) [10 citations, W4405514993]
JAMA Network Open|2024
10 cit.
10
Publication in BMJ Open Respiratory Research (2025) [5 citations, W4407500232]
BMJ Open Respiratory Research|2025
5 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Amany R. Mohammed
American Express (United States)
2
William E. Funk
Northwestern University
3
Elizabeth C. Oelsner
Columbia University
4
Raolat M. Abdulai
Sanofi (United States)
5
Chen Wang
Chinese Academy of Medical Sciences & Peking Union Medical College
6
Loems Zeigler-Heitbrock
Helmholtz Zentrum München
7
Manish Bodas
University of Oklahoma Health Sciences Center
8
Louise V. Wain
University of Leicester
9
Annette T. Hastie
Wake Forest University
10
Brian D. Hobbs
Brigham and Women's Hospital

Papers

1
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
New England Journal of Medicine|2023
458 cit.
2
The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020–50: a health-augmented macroeconomic modelling study
The Lancet Global Health|2023
457 cit.
3
Epidemiologic Features of Recovery From SARS-CoV-2 Infection
JAMA Network Open|2024
55 cit.
4
Collaborative Cohort of Cohorts for COVID-19 Research (C4R) Study: Study Design
American Journal of Epidemiology|2022
35 cit.
5
Lung function impairment and risk of incident heart failure: the NHLBI Pooled Cohorts Study
European Heart Journal|2022
35 cit.
6
Association of Symptoms After COVID-19 Vaccination With Anti–SARS-CoV-2 Antibody Response in the Framingham Heart Study
JAMA Network Open|2022
31 cit.
7
AERIFY-1/2: two phase 3, randomised, controlled trials of itepekimab in former smokers with moderate-to-severe COPD
ERJ Open Research|2024
30 cit.
8
Cluster analysis of transcriptomic datasets to identify endotypes of idiopathic pulmonary fibrosis
Thorax|2022
22 cit.
9
Type 2 inflammation biomarkers and their association with response to dupilumab in COPD (BOREAS): an analysis of a randomised, placebo-controlled, phase 3 trial
The Lancet Respiratory Medicine|2025
21 cit.
10
Demographic and Clinical Factors Associated With SARS-CoV-2 Spike 1 Antibody Response Among Vaccinated US Adults: the C4R Study
Nature Communications|2024
15 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Vito Brusasco
University of Genoa
2
Jadwiga A. Wedzicha
Imperial College London
3
Emiel F.�M. Wouters
Maastricht University
4
Jørgen Vestbo
Manchester Academic Health Science Centre
5
Peter J. Barnes
Imperial College London
6
Àlvar Agustí
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias
7
Bartolomé R. Celli
Brigham and Women's Hospital
8
Denis E. O’Donnell
Queen's University
9
Richard ZuWallack
Trinity Health
10
H Magnussen
LungenClinic Grosshansdorf

Papers

1
Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study
The Lancet|2005
4.7k cit.
2
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
European Respiratory Journal|2004
4.4k cit.
3
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
New England Journal of Medicine|2004
4k cit.
4
An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation
American Journal of Respiratory and Critical Care Medicine|2013
3.9k cit.
5
Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease
Unknown Journal|1995
3.5k cit.
6
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
New England Journal of Medicine|2007
3.3k cit.
7
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
American Journal of Respiratory and Critical Care Medicine|2017
3.2k cit.
8
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
New England Journal of Medicine|2010
3k cit.
9
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease
Thorax|1999
2.9k cit.
10
Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine|1998
2.3k cit.

Reagents for Chronic Obstructive Pulmonary Disease (COPD) Research

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 64

Phospho-PKC Antibody Sampler Kit

Cited in 7 papers
#9921$793
View Evidence →
Agilent/Dako

Mast Cell Tryptase

Cited in 7 papers
#M7052
View Evidence →
Cell Signaling TechnologyEvidence 67

Acetyl-CoA Carboxylase 2 (D5B9) Rabbit Monoclonal Antibody

Cited in 5 papers
#8578$161,351
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 67

Vimentin (D21H3) Rabbit Monoclonal Antibody (APC Conjugate)

Cited in 9 papers
#95159$465
View Evidence →
Cell Signaling Technology

DDX41 (D3F1Z) Rabbit Monoclonal Antibody

Cited in 8 papers
#15076$159,352
View Evidence →
Cell Signaling TechnologyEvidence 66

CSF-1R/M-CSF-R (D9A9Y) Rabbit Monoclonal Antibody (BSA and Azide Free)

Cited in 7 papers
#10131$865
View Evidence →